FindTrial
Sign In

Anti-MOG CNS demyelination with concomitant anti-NMDAR encephalitis

Anti-MOG CNS demyelination with concomitant anti-NMDAR encephalitis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900021249
Enrollment
Unknown
Registered
2019-02-03
Start date
2019-03-01
Completion date
Unknown
Last updated
2019-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

anti-MOG CNS demyelination and anti-NMDAR encephalitis

Interventions

Cases:Immunosuppressive

Sponsors

Shandong Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Clinical and antibody testing clearly diagnoses patients with MOG superimposed NMDA encephalitis and has ruled out other diseases.

Exclusion criteria

Exclusion criteria: MOG and NMDAR antibodies are negative

Design outcomes

Primary

MeasureTime frame
antibody;—

Countries

China

Contacts

Public ContactLi Jiao

Shandong Provincial Hospital

smeiljiao@163.com+86 15066151070

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026